InvestorsHub Logo
Followers 3
Posts 607
Boards Moderated 0
Alias Born 06/07/2010

Re: None

Friday, 07/29/2016 3:38:07 PM

Friday, July 29, 2016 3:38:07 PM

Post# of 314
July 29th, 2016-- Research analysts at HC Wainwright started coverage on shares of Seres Therapeutics Inc. (NASDAQ:MCRB) in a research report issued to clients and investors on Friday. The brokerage set a “buy” rating and a $50.00 price target on the stock. HC Wainwright’s price target points to a potential upside of 39.78% from the company’s previous close. -- http://www.com-unik.info/hc-wainwright-begins-coverage-on-seres-therapeutics-inc-mcrb/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MCRB News